vTv Therapeutics (VTVT) Reports In-Line Q3 EPS

vTv Therapeutics (NASDAQ: VTVT) reported Q3 EPS of ($0.05), in-line with the analyst estimate of ($0.05).

For earnings history and earnings-related data on vTv Therapeutics (VTVT) click here.

You May Also Be Interested In

• Meta stock jumps 5% premarket: Analysts bullish on new Muse AI agent
• Texas Instruments (TXN) Reiterated at Neutral by Cantor Fitzgerald on Upside to Earnings Power
• Cooper Companies tumbles on weak guidance, strategic review conclusion